Literature DB >> 9011581

Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea.

P J Wills1, R L Hall, W Chan, P J Cole.   

Abstract

Mucus retention in the lungs is an important feature of several respiratory diseases (Regnis, J.A., M. Robinson, D.L. Bailey, P. Cook, P. Hooper, H.K. Chan, I. Gonda, G. Bautovich, and P.T.P. Bye. 1994. Am. J. Respir. Crit. Care Med. 150:66-71 and Currie, D.C., D. Pavia, J.E. Agnew, M.T. Lopez-Vidriero, P.D. Diamond, P.J. Cole, and S.W. Clarke. 1987. Thorax. 42:126-130). On the mucus-depleted bovine trachea, the ciliary transport rate of sputum from patients with cystic fibrosis and bronchiectasis of other causes was slow, but the rate was doubled by increasing the sodium chloride content by 90 mM. Increasing the sputum osmolality by inspissation or by the addition of nonelectrolytes had a similar effect. The viscoelasticity of sputum, but not the bovine ciliary beat frequency, was markedly saline dependent over the pathophysiological range. This suggests that low mucus salinity, not (as is generally assumed) its under-hydration, contributes to its retention in bronchiectasis due to cystic fibrosis and other causes, probably by affecting its rheology. It also indicates how the genetic defect in cystic fibrosis might lead to impaired mucus clearance. Therapies that increase the osmolality of lung mucus might benefit patients with mucus retention.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9011581      PMCID: PMC507760          DOI: 10.1172/JCI119138

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  STUDIES ON PULMONARY SECRETIONS. I. THE OVER-ALL CHEMICAL COMPOSITION OF PULMONARY SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS, BRONCHIECTASIS, AND LARYNGECTOMY.

Authors:  L W MATTHEWS; S SPECTOR; J LEMM; J L POTTER
Journal:  Am Rev Respir Dis       Date:  1963-08

2.  Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.

Authors:  E M App; M King; R Helfesrieder; D Köhler; H Matthys
Journal:  Am Rev Respir Dis       Date:  1990-03

3.  Non-invasive sampling of nasal cilia for measurement of beat frequency and study of ultrastructure.

Authors:  J Rutland; P J Cole
Journal:  Lancet       Date:  1980-09-13       Impact factor: 79.321

4.  Effect of pH, viscosity and ionic-strength changes on ciliary beating frequency of human bronchial explants.

Authors:  C K Luk; M J Dulfano
Journal:  Clin Sci (Lond)       Date:  1983-04       Impact factor: 6.124

5.  Polyelectrolyte behaviour in mucus glycoproteins.

Authors:  S E Harding; J M Creeth
Journal:  Biochim Biophys Acta       Date:  1983-07-28

6.  Studies on pulmonary secretions. II. Osmolality and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy.

Authors:  J L Potter; L W Matthews; S Spector; J Lemm
Journal:  Am Rev Respir Dis       Date:  1967-07

7.  A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.

Authors:  M R Knowles; N L Church; W E Waltner; J R Yankaskas; P Gilligan; M King; L J Edwards; R W Helms; R C Boucher
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

8.  Cystic fibrosis compared with the immotile-cilia syndrome. A study of mucociliary clearance, ciliary ultrastructure, clinical picture and ventilatory function.

Authors:  H Kollberg; B Mossberg; B A Afzelius; K Philipson; P Camner
Journal:  Scand J Respir Dis       Date:  1978

9.  Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation.

Authors:  R C Boucher; M J Stutts; M R Knowles; L Cantley; J T Gatzy
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

10.  Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol.

Authors:  D Pavia; M L Thomson; S W Clarke
Journal:  Am Rev Respir Dis       Date:  1978-02
View more
  23 in total

1.  WHO guidelines for treatment of tuberculosis: the missing links.

Authors:  Muhammad Atif; Syed Azhar Syed Sulaiman; Asrul Akmal Shafie; Irfhan Ali; Mohamed Azmi Hassali; Fahad Saleem
Journal:  Int J Clin Pharm       Date:  2012-06-16

2.  Restoration of mucociliary transport in the fluid-depleted trachea by surface-active instillates.

Authors:  Stephen T Ballard; James C Parker; Charles R Hamm
Journal:  Am J Respir Cell Mol Biol       Date:  2005-12-15       Impact factor: 6.914

Review 3.  Timing of hypertonic saline inhalation for cystic fibrosis.

Authors:  Mark Elkins; Ruth Dentice
Journal:  Cochrane Database Syst Rev       Date:  2016-12-22

4.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

Review 5.  Mechanisms and applications of hypertonic saline.

Authors:  Mark R Elkins; Peter T P Bye
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

6.  Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects.

Authors:  M R Knowles; J M Robinson; R E Wood; C A Pue; W M Mentz; G C Wager; J T Gatzy; R C Boucher
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

7.  Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.

Authors:  M Robinson; A L Hemming; J A Regnis; A G Wong; D L Bailey; G J Bautovich; M King; P T Bye
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

Review 8.  Sputum induction for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis.

Authors:  Y Gonzalez-Angulo; C S Wiysonge; H Geldenhuys; W Hanekom; H Mahomed; G Hussey; M Hatherill
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-18       Impact factor: 3.267

9.  Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis.

Authors:  Catherine S Thompson; S Harrison; J Ashley; K Day; D L Smith
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

10.  Duration of action of hypertonic saline on mucociliary clearance in the normal lung.

Authors:  W D Bennett; J Wu; F Fuller; J R Balcazar; K L Zeman; H Duckworth; K H Donn; T G O'Riordan; R C Boucher; S H Donaldson
Journal:  J Appl Physiol (1985)       Date:  2015-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.